Angiotensin-converting enzyme inhibitors may increase risk of severe COVID-19 infection

MAH ALZobaidy, AH AlbuRghaif… - Annals of the …, 2021 - annalsofrscb.ro
Coronavirus is a pathogen that hasbeen known to medicine for a long time with 39 different
genotypes, which fall under the broad realm of Riboviria, which mainly target the human …

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and the risk of SARS-CoV-2 infection or hospitalization with COVID-19 disease: a …

IM Tleyjeh, AAB Abdulhak, H Tlayjeh… - American journal of …, 2022 - journals.lww.com
Background: SARS-CoV-2 infects its target cells via angiotensin converting enzyme 2
receptor, a membrane-bound protein found on the surface of many human cells. Treatment …

[HTML][HTML] Comparison of selected characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63

D Bačenková, M Trebuňová, T Špakovská… - Applied Sciences, 2021 - mdpi.com
The global pandemic known as coronavirus disease 2019 (COVID-19) was caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This review article …

Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies

G Pathangey, PP Fadadu… - American Journal of …, 2021 - journals.physiology.org
On March 11, 2020, the World Health Organization declared coronavirus disease 2019
(COVID-19) a pandemic, and the reality of the situation has finally caught up to the …

[HTML][HTML] Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection

M Amini Pouya, SM Afshani, AS Maghsoudi… - Daru Journal of …, 2020 - Springer
Objectives There are several types of research on the COVID-19 disease which have been
conducting. It seems that prevailing over the pandemic would be achieved only by mastering …

[HTML][HTML] Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19

PO Shatunova, AS Bykov, OA Svitich… - Journal of microbiology …, 2020 - microbiol.crie.ru
The SARS-CoV-2 virus is a pathogen causing the coronavirus infection that culminated in a
worldwide pandemic in 2020. It belongs to β-coronaviruses and has high genetic similarity …

[HTML][HTML] Cardiovascular system is at higher risk of affecting by COVID-19

SA Nejadghaderi, A Heidari, N Shakerian… - Acta Bio Medica …, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 has shown its potential to cause severe manifestations among individuals with
underlying cardiovascular disease (CVD). The patients infected with SARS-CoV-2 with pre …

[PDF][PDF] A review on covid-19 pandemic a global threat-current status and challenges and preventive strategies

S Sukumaran, S Sathianarayanan - Int J Appl Pharm, 2021 - academia.edu
Covid19 (Coronavirus) is a life-threatening virus that mainly affects our respiratory system,
kidney, and GIT tract. People with a low immune system in their body fall prey to it. This virus …

The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets

MMN Babadaei, A Hasan, SH Bloukh… - Journal of …, 2021 - Taylor & Francis
Researchers have reported some useful information about the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) leading to CoV disease 2019 (COVID-19). Several …

Inhibitors of the renin–angiotensin system: the potential role in the pathogenesis of COVID-19

Z Huang, Y Jiang, J Chen, Y Zhou - Cardiology Journal, 2020 - journals.viamedica.pl
Abstract Coronavirus disease 2019 (COVID-19), which initially began in China, has spread
to other countries of Asia, Europe, America, Africa and Oceania, with the number of …